Designed to provide broad exposure to the World ETFs category of the market, the WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) is a smart beta exchange traded fund launched on 06/16 ...

acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP). It becomes the first antibiotic in the beta-lactam class to be approved for SAB and ...

Android 16 Beta 3 is now available, marking platform stability phase. Beta updates focused on app developers, new tools added. New user-facing features include text outline, Auracast support.

Scientists have for the first time looked deep into the protein structure that may determine our vision - and discovered that ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever GSK (NYSE:GSK – Get Free Report) last released its quarterly earnings data ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

The firm has a market cap of £60.30 billion, a price-to-earnings ratio of 24.01, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. GSK has a one year low of GBX 1,282.50 ($16.60 ...

GSK markets and sells two meningitis vaccines, which earned >$1.4bn of revenues in 2024; an influenza vaccine, Fluarix, which earned >$400m revenues; a shingles vaccine which earned >$3.3bn ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in GSK plc ("GSK" or the "Company") (NYSE: GSK) of a class action securities lawsuit. CLASS DEFINITION: The ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...